SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-002297
Filing Date
2019-04-09
Accepted
2019-04-09 08:00:28
Documents
14
Period of Report
2019-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_040919.htm 6-K 10882
2 EXHIBIT 99.1 exh_991.htm EX-99.1 17635
3 GRAPHIC exh991_01.jpg GRAPHIC 191958
4 GRAPHIC exh991_02.jpg GRAPHIC 354482
5 GRAPHIC exh991_03.jpg GRAPHIC 182067
6 GRAPHIC exh991_04.jpg GRAPHIC 147284
7 GRAPHIC exh991_05.jpg GRAPHIC 185084
8 GRAPHIC exh991_06.jpg GRAPHIC 268362
9 GRAPHIC exh991_07.jpg GRAPHIC 246889
10 GRAPHIC exh991_08.jpg GRAPHIC 144912
11 GRAPHIC exh991_09.jpg GRAPHIC 154112
12 GRAPHIC exh991_10.jpg GRAPHIC 89481
13 GRAPHIC exh991_11.jpg GRAPHIC 63240
14 GRAPHIC exh991_12.jpg GRAPHIC 247507
  Complete submission text file 0001171843-19-002297.txt   3162216
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 19738487
SIC: 2834 Pharmaceutical Preparations